The Platform Group AG header image

The Platform Group AG

TPG

Equity

ISIN DE000A2QEFA1 / Valor 57796644

Xetra (2024-09-16)
EUR 8.36-1.42%

The Platform Group AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

The Platform Group AG is a prominent platform group in Europe that utilizes advanced software solutions to facilitate partnerships between eCommerce entities. The company operates a variety of software-based platform solutions that cater to a wide range of sectors and industries. With 20 platforms in 18 different sectors, The Platform Group AG enables connected partners, such as retailers and manufacturers, to list their products on over 50 online channels simultaneously. The company provides comprehensive services ranging from content and pricing to delivery and customs. Founded in 2012 with the platform schuhe24.de, The Platform Group AG has since expanded its operations to encompass over 20 platforms for both B2B and B2C in 18 industrial branches.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Strong Sales Growth

The Platform Group AG reported strong sales growth for the first quarter of 2024. The company saw a significant increase in sales, which has led to an upward revision of its annual forecast for the year. This growth is attributed to the successful integration of recent acquisitions and the expansion of its market presence.

Increased Earnings

In Q1 2024, The Platform Group AG experienced a notable increase in earnings. The company's earnings surpassed initial forecasts, reflecting the effectiveness of its strategic initiatives and operational efficiencies. This positive performance has bolstered investor confidence and set a promising tone for the rest of the year.

Positive Outlook

The Platform Group AG has confirmed a positive outlook for the remainder of 2024. Following the strong financial results in the first quarter, the company remains optimistic about its growth prospects. The management has reiterated its commitment to achieving its medium-term financial targets and delivering value to shareholders.

Dividend Announcement

Based on the robust financial performance in Q1 2024, The Platform Group AG has announced a dividend for its shareholders. This decision underscores the company's strong cash flow position and its dedication to returning capital to investors. The dividend is expected to be well-received by the market.

Revenue Increase

The Platform Group AG reported a significant increase in revenue for the first quarter of 2024. The revenue growth was driven by higher sales volumes and successful market expansion strategies. This increase in revenue has contributed to the overall financial strength of the company and supports its growth trajectory.

Summarized from source with an LLMView Source

Key figures

23.7%1Y
-59.8%3Y
%5Y

Performance

47.0%1Y
56.3%3Y
55.4%5Y

Volatility

Market cap

58 M

Market cap (USD)

Daily traded volume (Shares)

4,730

Daily traded volume (Shares)

1 day high/low

8.48 / 8.38

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 163523
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%USD 79.04
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%USD 57.33
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.01%USD 233.89
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.95%USD 28.26
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.75%EUR 6.98
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%USD 165.52
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%USD 115.86
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 461641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 137.00
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.38%USD 29.27
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 57.98